Sussex Pathology Network to Deploy Clinisys Laboratory Information System

ClinisysThe Sussex Pathology Network has chosen Clinisys for a laboratory information system (LIMS) that will help its labs to collaborate, building on the supportive relationship that developed during the COVID-19 pandemic.

A single, hosted instance of WinPath Enterprise will replace the existing four live LIMS systems in use at the three trusts and seven laboratories within the network, of which two are at the end of their life.

The replacement of these LIMS systems is crucial to ensure that the labs maintain their capability to deliver a comprehensive range of pathology services, supporting vital aspects such as diagnosis and treatment decisions, blood transfusion, and trauma care.

An implementation team will work alongside laboratory and IT staff to make sure the new LIMS also supports consistent, efficient, and high-quality processes - so clinicians and patients receive the same service, wherever they work or live.

Emily Gaskell, programme director, pathology, at NHS Sussex, said: "During the Covid-19 pandemic, our pathology laboratories worked more closely together, and that encouraged us to move forward and adopt the NHS England model for pathology networks.

"However, because most of the labs are spread along a long, thin, coastal patch, with very poor road communications, a hub and spoke model for all work is impractical.

"Instead, we want to focus on creating a consistent pathology service, so it doesn't matter whether you get a test in Rye or in Chichester; you will get the same test, and the same quality of results, in the same appropriate timeframe.

"To do that, one LIMS is essential. We see Clinisys WinPath as a key enabler for the network, and critical to improving services for people in Sussex."

The Sussex Pathology Network serves three trusts: East Sussex Healthcare NHS Trust, University Hospitals Sussex NHS Foundation Trust, and Queen Victoria Hospital NHS Foundation Trust.

The two acute trusts; East Sussex Healthcare NHS Trust and University Hospitals Sussex NHS Foundation Trust serve a population of around 2.3 million people, while Queen Victoria Hospital provides specialist burns and plastic surgery to a much larger population covering Sussex, Kent, Surrey and parts of South London.

Across the three trusts more than 7 million tests are carried out each year, and demand is growing by 5% per year. WinPath Enterprise will provide a stable, safe and secure platform for these essential services.

It will also enable better communications so laboratories can share workload and expertise, and support remote working. And, in time, it will enable the introduction of automation and AI technologies, so highly trained pathologists can focus on urgent and complex cases, where their expertise is most needed.

Emily Gaskell said: "This is not the only project that the network has on. We also need to deliver our business-as-usual service, invest in our operating model and workforce, and secure new equipment and communications.

"But we are very keen to progress. The new LIMS is an important first step towards our vision for all clinicians, patients and residents across Sussex to have access to a seamless pathology service, with the right test in the right place at the right time - every time."

Implementation is at an early stage, but the aim is to roll-out the new LIMS site by site, and to have the first two sites live by December next year.

Felice Di Rienzo, professional services director at Clinisys said: "We are delighted to be working with the Sussex Pathology Service on the deployment of this new LIMS. The project team want to work at pace, and we are absolutely up for that.

"We look forward to standing alongside the implementation team and the network's clinicians as they roll-out Clinisys WinPath as a stable, secure and safe platform for pathology services today and in the future."

About Clinisys

Clinisys enables healthier and safer communities as a global provider of intelligent diagnostic informatics solutions and expertise that redefine the modern laboratory across healthcare, life sciences, public health and safety. Millions of laboratory results and data insights are generated every day using Clinisys' platform and cloud-based solutions in over 3,000 laboratories across 34 countries.

Most Popular Now

AI Predictions for Colorectal Cancer: On…

Colorectal cancer (CRC) ranks second in leading causes of cancer-related deaths globally, according to the WHO. For the first time, researchers from Helmholtz Munich and the University of Technology Dresden...

Combining AI Models Improves Breast Canc…

Combining artificial intelligence (AI) systems for short- and long-term breast cancer risk results in an improved cancer risk assessment, according to a study published in Radiology, a journal of the...

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

Healthcare Chatbot: Expand Support with …

The Danish eHealth platform, sundhed.dk, has faced a substantial surge in requests from Danish citizens and has swiftly expanded its support and effectively adapt to the ongoing changes in queries due...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...